135 related articles for article (PubMed ID: 22990258)
1. Benefits and risks of aspirin use.
Lund JL; Stürmer T; Toft-Sørensen H
JAMA; 2012 Sep; 308(11):1089-90; author reply 1090. PubMed ID: 22990258
[No Abstract] [Full Text] [Related]
2. Benefits and risks of aspirin use.
DiNicolantonio JJ; O'Keefe JH; Lavie CJ
JAMA; 2012 Sep; 308(11):1088-9; author reply 1090. PubMed ID: 22990257
[No Abstract] [Full Text] [Related]
3. Hemorrhagic complications associated with aspirin: an underestimated hazard in clinical practice?
Siller-Matula JM
JAMA; 2012 Jun; 307(21):2318-20. PubMed ID: 22706838
[No Abstract] [Full Text] [Related]
4. Tighter aspirin control urged for patients with diabetes. Taking aspirin increases bleeding risk that is not always outweighed by the potential benefits for patients with low cardiovascular disease risk.
Heart Advis; 2010 Aug; 13(8):6. PubMed ID: 22792576
[No Abstract] [Full Text] [Related]
5. Association of aspirin use with major bleeding in patients with and without diabetes.
De Berardis G; Lucisano G; D'Ettorre A; Pellegrini F; Lepore V; Tognoni G; Nicolucci A
JAMA; 2012 Jun; 307(21):2286-94. PubMed ID: 22706834
[TBL] [Abstract][Full Text] [Related]
6. Fatal bleedings with prasugrel as part of triple antithrombotic therapy.
Savonitto S; Ferri M; Corrada E
Rev Esp Cardiol (Engl Ed); 2014 Mar; 67(3):225-6. PubMed ID: 24774401
[No Abstract] [Full Text] [Related]
7. Warfarin and aspirin use and the predictors of major bleeding complications in atrial fibrillation (the Framingham Heart Study).
Sam C; Massaro JM; D'Agostino RB; Levy D; Lambert JW; Wolf PA; Benjamin EJ;
Am J Cardiol; 2004 Oct; 94(7):947-51. PubMed ID: 15464686
[TBL] [Abstract][Full Text] [Related]
8. [Acetylsalicylic acid and gastrointestinal hemorrhages: preferably a lower dosage].
Tytgat GN; Vreeburg EM; van der Meer J
Ned Tijdschr Geneeskd; 1996 Nov; 140(45):2219-23. PubMed ID: 8984364
[No Abstract] [Full Text] [Related]
9. Acute upper gastrointestinal hemorrhage in an elderly woman taking aspirin and clopidogrel.
Ben-Menachem T; Dominitz JA
Clin Gastroenterol Hepatol; 2011 Aug; 9(8):649-52. PubMed ID: 21440673
[No Abstract] [Full Text] [Related]
10. A health impact assessment of increased aspirin use in Wales.
Williams WR
Public Health; 2006 May; 120(5):480; author reply 481. PubMed ID: 16549078
[No Abstract] [Full Text] [Related]
11. Letter: the burden of co-morbidity in the population contributes more to upper gastrointestinal bleeding than aspirin.
Crooks CJ; West J; Card TR
Aliment Pharmacol Ther; 2013 Jun; 37(11):1115. PubMed ID: 23656421
[No Abstract] [Full Text] [Related]
12. Aspirin for Stroke Prevention in Elderly Patients With Vascular Risk Factors: Japanese Primary Prevention Project.
Uchiyama S; Ishizuka N; Shimada K; Teramoto T; Yamazaki T; Oikawa S; Sugawara M; Ando K; Murata M; Yokoyama K; Minematsu K; Matsumoto M; Ikeda Y;
Stroke; 2016 Jun; 47(6):1605-11. PubMed ID: 27165949
[TBL] [Abstract][Full Text] [Related]
13. Re: Sørensen et al.: low dose aspirin.
Petroski D
Am J Gastroenterol; 2001 May; 96(5):1646. PubMed ID: 11374720
[No Abstract] [Full Text] [Related]
14. A long-term risk-benefit analysis of low-dose aspirin in primary prevention.
Wu IC; Hsieh HM; Yu FJ; Wu MC; Wu TS; Wu MT
Eur J Clin Invest; 2016 Feb; 46(2):130-40. PubMed ID: 26640116
[TBL] [Abstract][Full Text] [Related]
15. [Does combination therapy of aspirin plus antiplatelet therapy increase the risk of upper gastrointestinal hemorrhage?].
Kim JH
Korean J Gastroenterol; 2011 Apr; 57(4):205-6. PubMed ID: 21519172
[No Abstract] [Full Text] [Related]
16. Letter: the burden of co-morbidity in the population contributes more to upper gastrointestinal bleeding than aspirin--authors' reply.
Lanas A; Polo-Tomás M; Casado-Arroyo R
Aliment Pharmacol Ther; 2013 Jun; 37(11):1116. PubMed ID: 23656423
[No Abstract] [Full Text] [Related]
17. Aspirin therapy in diabetes mellitus.
Colwell JA
Diabetologia; 1997 Jul; 40(7):867. PubMed ID: 9243111
[No Abstract] [Full Text] [Related]
18. [Platelet inhibition and gastric problems].
Arnesen Ø; Riis JS
Tidsskr Nor Laegeforen; 2007 Jan; 127(1):64; author reply 64. PubMed ID: 17205099
[No Abstract] [Full Text] [Related]
19. Reversing the effects of antiplatelet agents in the setting of intracranial hemorrhage: a look at the literature.
Jaben EA; Mulay SB; Stubbs JR
J Intensive Care Med; 2015 Jan; 30(1):3-7. PubMed ID: 25492811
[TBL] [Abstract][Full Text] [Related]
20. Ischemic stroke and intracranial hemorrhage with aspirin, dabigatran, and warfarin: impact of quality of anticoagulation control.
Ho CW; Ho MH; Chan PH; Hai JJ; Cheung E; Yeung CY; Lau KK; Chan KH; Lau CP; Lip GY; Leung GK; Tse HF; Siu CW
Stroke; 2015 Jan; 46(1):23-30. PubMed ID: 25406148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
